Chattanooga Medical Investors is categorized under Health Services in Columbia, TN and active since 2004.
Chattanooga Medical Investors was established in 2004, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Bryant Oakley at the company’s single location by writing to 851 West James Campbell Boulevard, Columbia, Tennessee TN 38401 or by phoning (931) 381-6265. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Chattanooga Medical Investors |
| Contact Person: | Bryant Oakley |
| Address: | 851 West James Campbell Boulevard, Columbia, Tennessee 38401 |
| Phone Number: | (931) 381-6265 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
Chattanooga Medical Investors was started in 2004 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Bryant Oakley for inquiries that concern Chattanooga Medical Investors by calling the company number (931) 381-6265, as your correspondence is most welcome. Additionally, the physical location of the single location of Chattanooga Medical Investors can be found at the coordinates 35.614602,-87.065569 as well as the street address 851 West James Campbell Boulevard in Columbia, Tennessee 38401.
For its online presence, you may visit Chattanooga Medical Investors’s website at and engage with its social media outlets through on Twitter and on Facebook.